Kaufmann Gunnar F. 4
4 · Oncternal Therapeutics, Inc. · Filed Mar 18, 2020
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2020-03-17−14,260→ 14,260 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (14,260 underlying)
Footnotes (1)
- [F1]Fully vested on grant date.